Yosuke Tarumi

Yosuke Tarumi

Auto-generated profile, based on publicly available information

Yosuke Tarumi

Department of Obstetrics and Gynecology Kyoto Prefectural University of Medicine, Graduate School of Medical Science Kyoto Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KYKaori Yoriki
Kaori Yoriki
TMTaisuke Mori
Taisuke Mori
TKTetsuya Kokabu
Tetsuya Kokabu
HMHiroshi Matsushima
Hiroshi Matsushima
SUShiori Umemura
Shiori Umemura
JKJo Kitawaki
Jo Kitawaki
Estrogen-related receptor alpha (ERRα), which shares structural similarities with estrogen receptors, is associated with tumor progression in endometrial cancer, but little is known about the detailed underlying mechanism. We investigated whether ERRα, in cooperation with peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), could participate in epithelial-mesenchymal transition (EMT) in endometrial cancer through cancer-stromal interactions. Two endometrial cancer cell lines, Ishikawa and HEC-1A, transfected with ERRα/PGC-1α expression plasmids or silenced for ERRα expression, were co-cultured with telomerase-transformed human endometrial stromal cells (T-HESCs). We found that EMT-associated factors including vimentin, Snail, and zinc finger E-box binding homeobox 1 were upregulated in cancer cells overexpressing ERRα/PGC-1α and that transforming growth factor-beta (TGF-β) was induced in T-HESCs in the same conditions. In contrast, ERRα knockdown suppressed EMT-associated factors in cancer cells and TGF-β in T-HESCs. ERRα/PGC-1α overexpression increased the expression of EMT-associated factors after TGF-β exposure; however, it decreased E-cadherin at protein level. ERRα knockdown suppressed EMT-associated factors in the presence of TGF-β, whereas E-cadherin remained unchanged. Matrigel invasion assays revealed that ERRα knockdown attenuated the stimulation of migration and invasion by TGF-β. These findings suggest that ERRα is a potential target for inhibiting TGF-β-induced EMT through cancer-stromal interactions in endometrial cancer.

1 August 2015 in Gynecologic Oncology Reports
Verified
Journal Article
Open access
YTYosuke Tarumi
Yosuke Tarumi
TMTaisuke Mori
Taisuke Mori
IKIzumi Kusuki
Izumi Kusuki
FIFumitake Ito
Fumitake Ito
JKJo Kitawaki
Jo Kitawaki
•Malignant transformation of deep infiltrating endometriosis involving the bladder is quite rare.•We review eight relevant cases which have been reported.•This is the second case fulfilling Sampson and Scott criteria.

28 February 2022 in Cancers
Verified
Journal Article
Open access
PDF file
TKTetsuya Kokabu
Tetsuya Kokabu
KMKoji Masui
Koji Masui
YTYosuke Tarumi
Yosuke Tarumi
NNNaoki Noguchi
Naoki Noguchi
KAKohei Aoyama
Kohei Aoyama
TMTaisuke Mori
Taisuke Mori
This study aimed to evaluate the efficacy and safety of computed tomography-magnetic resonance imaging (CT-MRI)-guided multi-catheter interstitial brachytherapy for patients with bulky (≥4 cm) and high-risk, stage IIB–IVB advanced cervical cancer. Eighteen patients who underwent concurrent chemoradiotherapy with multi-catheter interstitial brachytherapy between September 2014 and August 2020 were enrolled. The prescribed dose of external beam radiotherapy was 45–50.4 Gy, and the brachytherapy high-dose-rate aim was 25–30 Gy per 5 fractions. The endpoints were four-year local and pelvic control rates, four-year disease-free and overall survival rates, and the adverse events rate. The median follow-up period was 48.4 months (9.1–87.5 months). Fifteen patients received concurrent cisplatin therapy (40 mg/m2, q1week). Four (22.2%), seven (38.9%), and seven (38.9%) patients had stage II, III, and IV cervical cancer, respectively. Pelvic and para-aortic lymph node metastases were observed in 11 (61.1%) and 2 (11.1%) patients, respectively. The median pre-treatment volume was 87.5 cm3. The four-year local control, pelvic control, disease-free survival, and overall survival rates were 100%, 100%, 81.6%, and 87.8%, respectively. Three (16.7%) patients experienced grade 3 adverse events, and none experienced grade 4–5 adverse events. CT-MRI-guided multi-catheter interstitial brachytherapy could be a promising treatment strategy for locally advanced cervical cancer.

31 January 2019 in Cellular Oncology
Verified
Journal Article
Closed access
PDF file
TKTetsuya Kokabu
Tetsuya Kokabu
TMTaisuke Mori
Taisuke Mori
HMHiroshi Matsushima
Hiroshi Matsushima
KYKaori Yoriki
Kaori Yoriki
HKHisashi Kataoka
Hisashi Kataoka
JKJo Kitawaki
Jo Kitawaki

23 May 2019 in Human Reproduction
Verified
Journal Article
Closed access
HKHisashi Kataoka
Hisashi Kataoka
TMTaisuke Mori
Taisuke Mori
HOHiroyuki Okimura
Hiroyuki Okimura
HMHiroshi Matsushima
Hiroshi Matsushima
FIFumitake Ito
Fumitake Ito
JKJo Kitawaki
Jo Kitawaki
Is a peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α)-mediated pathway involved in the development of endometriosis? PGC-1α plays critical roles in inflammation and cell proliferation of endometriotic tissues and may be involved in the development of endometriosis. Expression levels of PGC-1α are higher in ovarian endometrioma (OE) than normal endometrium (NE). PGC-1α also stimulates aromatase activity and promotes local estrogen biosynthesis in OE. This is a case-controlled biological study using endometrial cells and tissues derived from 23 women with, and 10 women without, OE. Ectopic endometriotic and eutopic endometrial stromal cells (SCs) were isolated and maintained in culture. PGC-1α was either overexpressed in the cells or knocked down using siRNA. The expression of PGC-1α and other factors during endometriosis was examined using real-time PCR and western blotting, cell proliferation was measured using Cell Counting Kit-8 (WST-8) assays and transcriptional activity was assessed using luciferase reporter assays. PGC-1α overexpression promoted the proliferation of OESCs in a time-dependent manner (P < 0.01 versus control) but not NESCs. PGC-1α stimulated aromatase (P < 0.01 versus control) and interleukin (IL)-6/IL-8 mRNA expression levels (P < 0.05 versus control for each) and led to inhibitor kappa B phosphorylation protein expression and upregulation of the apoptosis inhibitors X-linked inhibitor of apoptosis protein and survivin at mRNA level (P < 0.05 versus control for each). HX531, a selective retinoid-X receptor-α (RXRα) antagonist, suppressed the PGC-1α-induced cell proliferation (P < 0.05 versus control), aromatase/IL-6/IL-8/survivin mRNA expression (P < 0.05 versus control for each) and transcription reporter activity of PGC-1α in a dose-dependent manner (P < 0.01 versus control). Moreover, HX531 downregulated PGC-1α-induced aromatase-promoter PI.3-II transcripts in OESCs, and PGC-1α knockdown reduced aromatase, IL-6/IL-8 and antiapoptotic factors mRNA expression (P < 0.05 versus control for each). Notably, the Histogram score, which was used for quantifying RXRα status, was markedly higher in OE than in NE tissue (P < 0.01). N/A. Only OE tissues were included in this study, while peritoneal and deep infiltrating endometriotic tissues were not. Therefore, these findings might not be generalized to other types of endometriosis. In OESC, PGC-1α stimulated cell proliferation and was involved in local estrogen biosynthesis, inflammation and apoptosis, and these effects of PGC-1α were inhibited by HX531. The suppression of PGC-1α-induced proliferation by HX531 in OESCs but not NESCs suggests that the PGC-1α-RXRα axis could play critical roles in promoting endometriosis. This is the first report of a relationship between PGC-1α and inhibitor of apoptosis proteins in endometriosis. Based on these findings, the PGC-1α-mediated pathway could represent a potential target in molecular therapy of endometriosis. The study is supported in part by Grants-in-Aid for Scientific Research (15 K10681 and 15 K10726) from the Ministry of Education, Culture, Sports, Science, and Technology (Japan). The authors have no conflicts of interest to disclose.

2 March 2022 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
YTYosuke Tarumi
Yosuke Tarumi
TMTaisuke Mori
Taisuke Mori
KSKoki Shimura
Koki Shimura
YIYuko Izumi
Yuko Izumi
HOHiroyuki Okimura
Hiroyuki Okimura
JKJo Kitawaki
Jo Kitawaki
Context Progesterone resistance including progesterone receptor (PR) deficiency contributes to the pathophysiology of endometriosis; however, whether the PR expression levels in ovarian endometrioma (OE) correlate with the postoperative recurrence of endometriosis remains unclear. Objective This study aimed to investigate the association between PR expression levels in OE and the recurrence of endometriosis. Methods OE specimens were obtained from 132 patients who underwent conservative surgery for endometriosis. The PR expression levels were evaluated using the H-score after immunohistochemical staining. Results Of the 132 patients, 36 (27.3%) experienced recurrence and 96 (72.7%) did not. No differences were observed in the patient characteristics between the recurrence and nonrecurrence groups except for follow-up period. PR immunoreactivity in the epithelial cells (ECs) was significantly lower in the recurrent group than in the nonrecurrent group (P < 0.01); however, this change was not observed in the stromal cells. Moreover, multivariable logistic regression analysis revealed that the H-score of PR in ECs was an independent factor and significantly associated with the recurrence of endometriosis (P = 0.01). Furthermore, we divided the patients into PR negative or PR positive groups. The cumulative recurrence rate in the negative PR group was significantly higher than that in the positive PR group (P = 0.046). Conclusion Low PR expression levels in OE-ECs may predict the recurrence of endometriosis. The PR status in OE-ECs is associated with the pathophysiology of the recurrence of endometriosis, and optimized postoperative management for endometriosis may be provided by referring to the PR status.